Home  »  Markets   »  Allarity Therapeutics Inc. (ALLR) Looks Ready for ...

Allarity Therapeutics Inc. (ALLR) Looks Ready for Growth Despite 0.07% Change This Year

Allarity Therapeutics Inc. (NASDAQ: ALLR) is 0.07% higher on its value in year-to-date trading and has touched a low of $0.20 and a high of $9.67 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ALLR stock was last observed hovering at around $0.25 in the last trading session, with the day’s gains setting it 0.04% off its average median price target of $8.00 for the next 12 months. It is also 96.38% off the consensus price target high of $8.00 offered by 1 analysts, but current levels are 96.38% higher than the price target low of $8.00 for the same period.

Currently trading at $0.29, the stock is 21.36% and -16.61% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 43.54 million and changing 15.84% at the moment leaves the stock -74.19% off its SMA200. ALLR registered -96.43% loss for a year compared to 6-month loss of -73.51%.

5 Undervalued Stocks For 2023

Approximately 544 miles north of Las Vegas lies what's been dubbed "the biggest lithium deposit in the US." One tiny company stands to be the biggest beneficiary because lithium "faces a long-term supply shortage," according to Barron's. This company, however, is sitting on a goldmine opportunity as it plans to produce 30,000 tonnes per annum over the next 3.5 years from this single deposit. Supplying the electric vehicle boom and potentially driving its stock price off the charts. But this is just one of the opportunities we have researched in our free report. The other four companies have just as much potential.

Click here to download your Free Copy…


The stock witnessed a 7.22% gain in the last 1 month and extending the period to 3 months gives it a -62.31%, and is 20.49% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 27.73% over the week and 23.13% over the month.

Distance from 52-week low is 47.00% and -96.96% from its 52-week high.

Allarity Therapeutics Inc. (ALLR) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Allarity Therapeutics Inc. (ALLR) is a “Hold”. 1 analysts offering their recommendations for the stock have an average rating of 3.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Allarity Therapeutics Inc. is expected to release its quarterly report on 05/26/2023.The EPS is expected to shrink by -412.60% this year.

Allarity Therapeutics Inc. (ALLR) Top Institutional Holders

The shares outstanding are 9.87M, and float is at 8.41M with Short Float at 1.86%.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts